While GLP-1 therapy can reduce symptoms for some people, it might not be the right option for others, and its your healthcare providers job to help you find a treatment that suits you
Additionally, proving errors in drug testing or chain of custody can be used to challenge the positive test result
[PMID: 39894345] PubMed record related to this compound for laboratory literature review
King A, Miller EM
Tirzepatide is the first in its class, being a single-molecule agonist of both the GLP-1 receptor and the receptor for glucose-dependent insulinotropic polypeptide (GIP), hence the term dual agonist or twincretin
Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Cahen DL, van Raalte DH